Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
IsraelWithdrawnPHASE1, PHASE2
Conditions
Chronic Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hadassah Medical Organization, Jerusalem, Israel
Study leads
Shimon Slavin, MD
Principal Investigator
Hadassah Medical Organization